Axsome Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Axsome Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Axsome Therapeutics Inc
Rating: 1.053847125
Author: Trendlyne DVM scores

Weak Stock

about

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

157.14 -4.65 (-2.87%)

39.61% Fall from 52W High

873.1K

XNAS Volume

XNAS 16 Oct, 2026 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

6.8 / 100

Technically Bearish

33.0 / 100

Weak Stock These stocks have poor scores across the board. Investors should be very cautious with these stocks View Similar Embed DVM

283

1Yr Price target upside is 80%

22 analysts

Axsome Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Axsome Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

39.61% Fall from 52W High

SWOT Analysis

Axsome Therapeutics Inc Live Price Chart

Axsome Therapeutics Inc Live Price Chart